Contaminated sodium acetate injection USP not recalled in Canada due to shortage News item 26 March 2022 Pages: 1 - 1
MHRA issues new advice to monitor for liver injury from cladribine treatment News item 26 March 2022 Pages: 2 - 2
Reminder to monitor for adverse lung, liver and thyroid changes with amiodarone treatment News item 26 March 2022 Pages: 4 - 4
Revisions of package inserts for efavirenz, nintedanib and ticagrelor News item 26 March 2022 Pages: 5 - 5
Anticoagulant-related intracranial haemorrhage underreported Clinical study 26 March 2022 Pages: 6 - 6
Campylobacteriosis may masquerade as ibrutinib-related adverse events Clinical study 26 March 2022 Pages: 7 - 7
Glatiramer acetate not associated with adverse pregnancy, foetal, or infant outcomes Clinical study 26 March 2022 Pages: 8 - 8
Risk of major bleeding: DOACs vs LMWH for thromboprophylaxis in non-cardiac surgery Review 26 March 2022 Pages: 9 - 9
Risk of postoperative hypoxaemia during opioid analgesic shortages Clinical study 26 March 2022 Pages: 10 - 10
Some sulfonylureas increase risk of MACE in patients with T2DM Clinical study 26 March 2022 Pages: 11 - 11